Muscular Dystrophy
|
0.180 |
Biomarker
|
disease |
BEFREE |
We screened a large cohort of muscular dystrophy patients for abnormalities in FHL1 (n=102) and TCAP (n=100) and selected patients whose clinical features overlapped the phenotypes previously described for BAG3 (n=9), MATR3 (n=15) and PTRF (n=7).
|
21683594 |
2011 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
GeneticVariation
|
disease |
BEFREE |
We report novel PTRF mutations and detailed phenotypes of two male and three female patients with CGL4 belonging to two pedigrees of Mexican origin (CGL7100 and CGL178) and one pedigree of Turkish origin (CGL180).
|
20684003 |
2010 |
Lipodystrophy
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
We identified two new PTRF homozygous mutations (p.Asp59Val or p.Gln157Hisfs*52) in four patients with CGL4 presenting with generalized lipoatrophy and associated metabolic abnormalities.
|
27144934 |
2016 |
Lipoatrophy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
We identified two new PTRF homozygous mutations (p.Asp59Val or p.Gln157Hisfs*52) in four patients with CGL4 presenting with generalized lipoatrophy and associated metabolic abnormalities.
|
27144934 |
2016 |
Ewings sarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We identified differential hypermethylation of CpGs located in the body and S-Shore of the PTRF gene in Ewing sarcoma that correlated with its repressed transcriptional state.
|
27894957 |
2017 |
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We have identified two proteins, PTRF/cavin-1 and MIF, which are differentially expressed between normal lung and non-small cell lung cancer.
|
22461895 |
2012 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Using a combined in silico and in vitro analysis here we show that Cavin-1 is expressed in myogenic RMS tumors as well as in human and primary mouse RMS cultures, exhibiting a broad subcellular localization, ranging from nuclei and cytosol to plasma membrane.
|
25822667 |
2015 |
Cardiac Arrhythmia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Two patients with CGL4 developed hypertrophic cardiomyopathy (HCMP) and severe cardiac arrhythmia, only one patient with CGL1 had HCMP.
|
31778856 |
2019 |
Adverse Event Associated with Cardiac Arrhythmia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Two patients with CGL4 developed hypertrophic cardiomyopathy (HCMP) and severe cardiac arrhythmia, only one patient with CGL1 had HCMP.
|
31778856 |
2019 |
Hypertrophic Cardiomyopathy
|
0.110 |
Biomarker
|
disease |
BEFREE |
Two patients with CGL4 developed hypertrophic cardiomyopathy (HCMP) and severe cardiac arrhythmia, only one patient with CGL1 had HCMP.
|
31778856 |
2019 |
Hypertrophic obstructive cardiomyopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Two patients with CGL4 developed hypertrophic cardiomyopathy (HCMP) and severe cardiac arrhythmia, only one patient with CGL1 had HCMP.
|
31778856 |
2019 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
Biomarker
|
disease |
BEFREE |
To the best of our knowledge, we present a novel mutation of PTRF from Saudi Arabia and our findings broaden the mutation spectrum of PTRF in the familial CGL4 phenotype.
|
25721873 |
2015 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, these findings, for the first time, demonstrated that PTRF inhibits the tumorigenesis of colorectal cancers and that it might serve as a potential therapeutic target for human colon cancer patients.
|
27203393 |
2017 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Thus, these findings, for the first time, demonstrated that PTRF inhibits the tumorigenesis of colorectal cancers and that it might serve as a potential therapeutic target for human colon cancer patients.
|
27203393 |
2017 |
Muscular Dystrophy
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Thus, in addition to compromised adipocyte-related physiology, the absence of PTRF/cavin-1 in mice caused a unique form of muscular dystrophy with a phenotype similar or identical to that seen in humans lacking this protein.
|
28289716 |
2017 |
Cervix carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results suggest there may be a functional role for the modulation by glycosylation of GLUT1 in the tumorigenic behavior of CGL4 and HeLa cells.
|
8719880 |
1995 |
Myeloid Leukemia, Chronic
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
There are four subclinical phenotypes of CGL (CGL1-4) and mutations in four genes AGPAT2, BSCL2, CAV1 and PTRF have been assigned to each type.
|
23659685 |
2013 |
Glioma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The predictive role of CAVIN1 in progressive malignancy in glioma was evaluated by using a receiver operator characteristic (ROC) curve.
|
30311408 |
2019 |
Glioblastoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
The mRNA level of PTRF and caveolin1 showed a positive correlation in the same GBM specimens.
|
24747515 |
2014 |
Glioblastoma Multiforme
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
The mRNA level of PTRF and caveolin1 showed a positive correlation in the same GBM specimens.
|
24747515 |
2014 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The major genetic factors in the generalized forms of the lipodystrophies, particularly Congenital generalized lipodystrophy (CGL)-Berardinelli-Seip syndrome, are the AGPAT2, BSCL2, caveolin 1 (CAV1) and polymerase-I-and-transcriptrelease factor (PTRF) genes.
|
24152769 |
2014 |
Lipodystrophy
|
0.340 |
Biomarker
|
disease |
BEFREE |
The major genetic factors in the generalized forms of the lipodystrophies, particularly Congenital generalized lipodystrophy (CGL)-Berardinelli-Seip syndrome, are the AGPAT2, BSCL2, caveolin 1 (CAV1) and polymerase-I-and-transcriptrelease factor (PTRF) genes.
|
24152769 |
2014 |
Myopathy
|
0.130 |
Biomarker
|
group |
BEFREE |
The PTRF gene should be investigated in patients with hyperCKemia, mild myopathy associated with spontaneous or percussion-induced muscle contractions like rippling or mounding, and no CAV3 mutation.
|
24024685 |
2013 |
Prostate Cancer, Hereditary, 7
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Taken together, our results suggest that PTRF/cavin-1 expression alters prostate cancer aggressiveness.
|
20732728 |
2011 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
Reintroduction of PTRF/Cavin-1 in Ewing sarcoma cells revealed a role of this protein as a tumor suppressor.
|
27894957 |
2017 |